#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Methylmalonic acidaemia Idiopathic intracranial hypertension Immune-mediated renal disorder Rett syndrome Univentricular heart Castleman's disease Squamous cell carcinoma of the oral cavity Neonatal alloimmune thrombocytopenia Bulbospinal muscular atrophy congenital Candida infection Nephropathy Lymphoma Acute graft versus host disease in intestine Chronic myeloid leukaemia (in remission) Chronic inflammatory demyelinating polyradiculoneuropathy More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Treatment Toxic epidermal necrolysis – Diagnostics Behcet’s syndrome Rhabdomyosarcoma – Treatment Prolymphocytic leukaemia – Trials in Disease Mucopolysaccharidosis – Trials in Disease Glycogen storage disease type I Hereditary motor and sensory neuropathy – Treatment Pleomorphic leiomyosarcoma – Life with Disease Leiomyosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Febuxostat S227928 Cyanocobalamin GSKVX000000040033 Sertraline Argatroban Monohydrate GSK4524101A Hst-1011 RO7288817 Kd050 Oxaliplatin GRNA1599 Dactylis Glomerata 177Lu-Dpi-4452 Dupilumab Methylphenidate Hydrochloride Nirogacestat Hydrobromide Levamlodipine Succinate Disulfiram Mirabegron More therapies…

    Learn about Your Condition

    Marfan's syndrome Glomerulonephritis acute Stevens-Johnson syndrome Pyrexia Testicular leiomyosarcoma Gallbladder cancer Genitourinary tract neoplasm Turner's syndrome Facial paresis Colon cancer stage II Bladder cancer stage III Crohn's disease Astrocytoma malignant Haemodynamic instability Fontan procedure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Effects of Aspirin and Omeprazole in Obese and Non-Obese Patients with Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain
  • Study on the Effect of Ropivacaine Hydrochloride and Sodium Chloride on Recovery After Inguinal Hernia Surgery for Patients Undergoing Open Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Inguinal hernia
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride
    Finland
  • Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Dostarlimab
    • Oxaliplatin
    Belgium Italy Spain
  • Study on STC-1010 and Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Hct116-A
    • Hct116-B
    Belgium France
  • Study on Reducing Fluid Use During Cancer Surgery with Argipressin for Patients with Disseminated Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Argipressin
    The Netherlands
  • Study on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Disodium Folinate
    • Irinotecan Hydrochloride Trihydrate
    • Calcium Folinate Pentahydrate
    Germany
Previous Page
1 … 26 27 28 29 30 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!